Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
80.20
-0.80 (-0.99%)
Aug 4, 2026, 3:56 PM CET

Oncoinvent ASA Income Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28.078.10.356.280.77
Revenue Growth
246.40%2188.98%-94.37%711.76%28.79%
Gross Profit
28.078.10.356.280.77
Selling, General & Admin
69.7259.08-55.6153.38-74.05
Depreciation & Amortization Expenses
11.2514.56-0.227.99-1.31
Other Operating Expenses
105.4375.49-136.3555.53-239.88
Total Operating Expenses
186.4149.12-192.17116.89-315.24
Operating Income
-158.33-141.02-191.82-110.61-314.46
Interest Income
4.11.55---
Other Non-Operating Income (Expense)
3.260.821.424.335.1
Total Non-Operating Income (Expense)
7.362.361.424.335.1
Pretax Income
-150.97-138.65-190.4-106.28-309.36
Net Income
-150.97-138.65-190.4-106.28-309.36
Net Income to Common
-155.07-140.2-190.4-106.28-309.36
Net Income Growth
-----
Shares Outstanding (Basic)
124251411
Shares Outstanding (Diluted)
124251411
Shares Change
395.91%74.59%1527.28%-17.40%
EPS (Basic)
-1.25-5.61-13.00-548.00-352.00
EPS (Diluted)
-1.25-5.61-13.00-548.00-352.00
EPS Growth
-----
Free Cash Flow
-129.99-89.75-225.1-93.17-303.34
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.05-3.59-15.73-105.93-344.88
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-564.07%-1740.32%-54186.20%-1760.48%-40628.40%
Profit Margin
-537.84%-1711.14%-53785.60%-1691.55%-39969.50%
FCF Margin
-463.11%-1107.55%-63587.90%-1482.94%-39191.20%
EBITDA
-147.08-126.46-191.6-102.62-313.15
EBITDA Margin
-523.99%-1560.69%-54123.20%-1633.36%-40458.90%
EBIT
-158.33-141.02-191.82-110.61-314.46
EBIT Margin
-564.07%-1740.32%-54186.20%-1760.48%-40628.40%